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Since Nuttall's (1)  initial observation that cell-free  serum is destructive of 
bacteria, other investigations (2)  have disclosed that bacterial lysis by serum 
usually occurs as a result of the interaction of a specific antibody and comple- 
ment.  However,  bactericidal  effects for many different microorganisms can 
frequently be found in the same serum (3). Often this bactericidal activity can- 
not be  satisfactorily explained on an ecological basis.  The characteristics of 
naturally occurring bacteriolytic substances have therefore been obscure and 
differing opinions have resulted concerning their immunologic specificity. The 
investigations by Mackie and Finklestein indicated that naturally occurring 
bactericidins are immunologically  specific since absorption by homologous organ- 
isms removed specific antibodies. Gordon and Carter (4), however, were unable 
to  demonstrate any specificity for  the  naturally occurring bactericidal sub- 
stances. 
The observations of Dresel and Keller (5)  are of particular interest in this 
respect. These investigators studied the bactericidal action of human sera for 
Bacillus anlhracis.  Normal  sera  were  found to  produce  little anthracoccidal 
effect, whereas sera of patients with a variety of acute febrile illnesses uniformly 
had  considerable destructive action for B.  anthracis.  Correspondingly, a  de- 
creasing anthraeoccidal activity developed during convalescence and recovery. 
Similar observations  were  reported  by Tillett  (6)  for  susceptible  strains  of 
Streptococcus hemolyticus.  He observed  that  patients with pneurnococal lobar 
pneumonia developed an increased serum bactericidal action for streptococci. 
Subsequently, a  progressive  decrease  occurred  during convalescence and re- 
covery. Hjorth (7)  reported a  comparable phenomenon for other microorgan- 
isms. 
An interest in the nature of this non-specific enhancement of bactericidal 
activity of human serum during acute illness prompted reinvestigation of this 
subject. In order to eliminate as nearly as possible, any influence of acquired 
* Research carried out under a grant for the study of rheumatic fever from the Masonic 
Foundation  for Medical Research  and  Human  Welfare. 
101 102  ACTIVATING  E~FECT 0P CALCIUM 
specific antibodies, a bacterium was used which is rarely capable of producing 
human  infections. The bactericidal effect of normal and acute phase sera for 
Bacillus subtilis was therefore studied. The results reveal that serum develops 
a significant increase of destructive action for this organism during the acute 
stage of a variety of diseases. If repeated determinations of bactericidal activity 
are made in an individual patient, a progressive decrease of destructive action 
occurs during convalescence and recovery. A point of particular significance is 
that the serum bactericidal factor for B. subtilis requires calcium. A  strongly 
bactericidal serum can be made completely unreactive for B. subtilis if calcium 
is removed. If an optimum calcium concentration is restored to such a serum, 
it again becomes bactericidal. 
EXPERIMENTAL 
(a)  Human blood to be studied for bactericidal activity against B. subtiUs was collected 
under aseptic conditions in glass test tubes and allowed to coagulate. Serum was then collected 
after centrifugation and stored in glass test tubes at ice box temperatures (4°C.). No significant 
decrease of bactericidal activity was detected after 6 to 8 months' storage under these con- 
ditions. 
(b)  The bactericidal studies were carried out with a strain of Bacillus subtilis obtained from 
the Department of Bacteriology's type collection. This particular strain was found to resist 
the bactericidal action of penicillin up to a concentration of 5 units per millilitre. Thus, assay 
of sera of patients undergoing antibiotic therapy with penicillin could be carried out. A quan- 
titative determination of serum bactericidal activity for B. subtilis was made by determining 
the residual bacterial count after incubation of serum with a  suspension of organisms. This 
was done by plate counts of serial tenfold dilutions of inoculum and similar dilutions of serum 
to which organisms had been previously added. 
The inoculum of B. subtilis was prepared by inoculating 0.2 ml. of a  24 hour growth of 
B.  subtilis into a  test tube containing 10 ml. of  Douglas broth. The inoculated broth was 
incubated at 37°C.  until a  diffuse homogeneous growth had resulted (usually 3  to 4 hours). 
The suspension was then centrifuged for 10 minutes at 2500 a.P.~t,  in order to sediment the 
bacteria. The broth was removed by decantation and the bacteria were resuspended in 10 ml. 
of 0.85 per cent sodium chloride solution (pH 7.3)  and mixed until a  uniform suspension was 
obtained. This suspension usually contained 2 to 3 million organisms in each 0.1 ml. and was 
utilized for inoculation of sera to be tested. 
Aliquots of 0.1 ml. of the saline suspension of B. subtilis were added to 0.5 ml. amounts of 
sera contained in cotton-stoppered,  sterile glass tubes measuring 0.5  X  3.0 cm.  Sufficient 
0.85 per cent sodium chloride solution was then added  to bring the volume of serum and 
inoculated organisms to  1.0 ml. The mixture was vigorously shaken and incubated at 37  °. 
At a varying period thereafter (usually 2 hours) an aliquot of 0.1 ml. was removed and serial 
tenfold dilutions were made in Douglas broth. A  0.1  ml. aliquot of each of these dilutions 
was pipetted into a  Petri dish. To this was added approximately 15 ml. of melted Douglas 
agar and by vigorous rotation the organisms were thoroughly distributed within the agar. 
After incubation for 18 hours at 37°C., a colony count was made of the agar plates in which 
10 to 200 colonies had grown. The number of colonies multiplied by the dilution factor repre- 
sented the number of bacteria contained in a particular inoculum or serum-inoculum mixture. 
All dilutions were carried out by using a separate sterile pipette for each dilution. 
In many instances, triplicate assays were made both of the sera to which B. sub~ilis had 
been added  and of  the inoculating suspension. When the enumeration of bacteria by this RALPH  F..]'ACOX  103 
technique resulted in a range of 50,000 to 90,000 bacteria a variation of 4- 10,000 bacteria 
was present. When the range was 500,000 to 1,000,000 organisms, a variation of -4- 100,000 
was found. In the range of 1,000,000 to 4,000,000 a considerable error was present. As will 
be observed in subsequent experiments, no significance was given to any result which did 
not fall considerably beyond these variations. 
TABLE I 
Inhibition of B. subtilis by Human Sera* 
Serum No.  Residual  organisms after 
incubation for 2 hrs.  Diagnosis 
4 
5 
6 
7 
8 
9 
9a 
9b 
10 
11 
12 
13 
14 
15 
16 
1,000,000 
4,000,000 
3,200,000 
45,000 
2,000 
4,900 
2,000 
180 
3 
No growth 
70,000 
910,000 
No growth 
440,000 
200,000-250,000 
11,000 
850 
No growth 
2O 
No growth 
Original inoculum 
Normal individual 
Normal  " 
Chronic bronchopleural fistula 
Low grade fever. No leucocytosis 
Tuberculous pleural effusion 
Infectious hepatitis 
Ulcerative colitis. No fever 
Acute rheumatoid arthritis 
"  rheumatic fever 
Lobar pneumonia. Type II pneumococcus 
"  "  3rd day. Temp. 38°C. 
"  "  2nd wk. Recovery. 
Carcinoma of rectum 
Original inoculum 
3 normal individuals 
Acute bronchitis 
Erysipelas 
Orchitis secondary to epidemic parotitis 
Poliomyelitis--Temp. 38.5°C. 
Serum sickness--Temp. 39°C. 
* Five-tenths mlllilltre aliquots of sera 1 to  10 were inoculated with 0.1 ml. suspension 
of B.  s~t/l/s containing 1,000,000 organisms; sera 11 to 16 were similarly inoculated with 
440,000 organisms. After 2 hours' incubation at 37°C., an enumeration of the residual bac- 
teria was made by plate count. 
Bactericidal Action of Human Sera for B. subtilis:---The data shown in Table 
I  are representative of assays made on approximately 300 abnormal and 100 
normal human sera. The results of a study of normal serum obtained from medi- 
cal students and a group of adolescent boys reveal that an insignificant degree 
of bactericidal activity for B. subtilis is present. No inhibition of growth is ap- 
parent  when  a  large  inoculum is  used,  whereas  a  slight  inhibitory effect  is 
found after  inoculation of fewer bacteria.  In instances in which a  moderate 
increase of bactericidal activity is found in a  presumed normal individual, a 
respiratory infection is usually present to explain the observed elevation. 104  ACTIVATING  E~'FECT  O~  CAL~JIo~ 
In distinction to the results found in normal sera, abnormal sera obtained 
from a  group of patients with a variety of medical and surgical diseases show 
striking increases of bactericidal activity for B. subtilis. This enhanced bacteri- 
cidal effect is present in the sera of patients with such unrelated diseases as 
carcinomatosis,  coronary occlusion, orchitis resulting from the  virus  of epi- 
demic parotitis,  bacterial pneumonia,  acute rheumatic fever,: or  tuberculosis 
(Table I). 
A study of thirty patients with bacterial lobar pneumonia of different pneu- 
mococcal types reveals that during the acute phase of the illness a  complete 
destruction of as many as 3 to 4 million B. subtilis organisms for each 0.5 ml. 
of serum occurs. During convalescence and recovery, a progressive decrease in 
the inhibitory effect results. Whenever a patient with lobar pneumonia received 
large amounts of penicillin, the serum inhibitory effect for B. subtil~s could be 
blocked by the  addition of potassium  oxalate, demonstrating that penicillin 
was not causing destruction of this microorganism. 
The bactericidal activity of sera from fifteen patients with acute rheumatic 
fever was  studied. Most  of these  patients  had  6  to  8  determinations made 
throughout the course of their illness.  During the acute phase of this illness, 
complete destruction of I  to 2 million organisms for each 0.S ml. of serum is 
observed. Subsequently, a decreasing bactericidal effect is found as the patient 
recovers. This decrease does not necessarily parallel a  decrease of temperature 
but usually correlates well with a  decreasing erythrocyte sedimentation rate. 
The degree of enhanced bactericidal effect cannot be correlated with the in- 
crease of circulating leucocytes or lymphocytes. In a group of 20 patients with 
various types of malignant disease, many were found to have normal tempera- 
tures and normal leucocyte counts. The sera of these patients, however, con- 
sistently reveal a  significantly enhanced bactericidal activity for B.  subtilis. 
The sera of five patients with acute myocardial infarction were assayed for 
bactericidal activity. A moderate increase is usuaUy found within 24 hours of 
the onset of a coronary occlusion, whereas a marked increase occurs after 3 to 
4 days, the period of maximum muscle necrosis. As the patients recover a  de- 
creasing bactericidal activity is found. Observations made on sera of patients 
with  rheumatoid  arthritis,  tuberculosis,  bacterial  peritonitis,  miscellaneous 
virus infections, or allergic reactions such as serum sickness reveal similar en- 
hancement of bactericidal effect for B. subtilis.  In these instances also, the de- 
gree of increased bactericidal effect appears to be a  reflection of the degree of 
stress to which the individual is subjected. 
The killing action of serum possessing increased bactericidal activity takes 
place soon after B. subtilis is added to it. Within S minutes following addition 
d  as many as 6,000,000  organisms to 0.S ml. of potent serum the number of 
bacteria are reduced to several thousand. Within  IS minutes  the number of 
organisms is reduced to a few hundred, and an hour later no organisms can be RA~.PH ~. 3Acox  10,5 
detected. Serial stained smears of the serum-bacterial mixture confirm the rapid 
disappearance of bacteria.  Sera which have insuflficient bactericidal effect to 
cause complete destruction of bacteria show a  similar rapid initial decrease of 
organisms. A maximum decrease is present after 90 to 120 minutes of incuba- 
tion at 37°C., following which time, bacterial proliferation begins and within 
24 hours, a  dense flocculent growth results. 
Influence of Physical Changes on Serum Bactericidal Substances- 
The effect of pH on bacterial growth and the inhibitory factor of serum was determined 
by the addition of 0.1 N HCI or 0.1 s  NaOH to serum in sufficient quantity to produce a pH 
range of 6.4--9.4 (determined by glass electrode). Each sample of serum was kept at a constant 
Effect  Of Variation  in ] 
6.4 
7.4 
8.5 
9.5 
TABLE  II 
,H on Bactericidal  Activity of Human Sera for B. subtilis* 
Normal serum 
No.  I 
2.09  X  10' 
1.9  X  10  I 
0.95  X  lO  s 
0.004 X  10  e 
Acute rheumatic  fever serum 
No. 2 
31.0 X  10  ~ 
0.6X  10  z 
1.7 X  10  ~ 
3.2 X  10  s 
* A normal and an acute phase serum were adjusted to varying degrees of pH. One-tenth 
millilitre of a  suspension of B. subtilis containing 1,000,000  organisms was inoculated. The 
residual bacteria, after incubation for 2 hours at 37°C., were determined by means of plate 
counts of serial tenfold dilutions of serum and bacteria mixture. 
volume by the addition of necessary amounts of 0.85 per cent sodium chloride solution of 
desired pH. B. subtilis was then inoculated into the respective sera, which were incubated for 
2 hours at 37°C. The results of this experiment are shown in Table II. 
Normal serum exhibits little change in bactericidal activity in the range of 
pH  7.4-8.4.  At pH 6.5  a  slight increase in bacterial growth is observed. At 
pH 9.4  bacterial growth is considerably inhibited. The serum possessing in- 
creased bactericidal activity shows little change in inhibitory level in the pH 
range of 7.4-8.4.  Some decrease of inhibition occurs at pH 6.4 and 9.4.  Since 
serum after storage at 4°C. is found to have pH values of 7.6-8.4, it is unlikely 
that this variation has any influence on its bactericidal activity for B. subtilis. 
Prolonged storage of serum at 4°C. causes no significant decrease of bacteri- 
cidal activity. When such stored sera are analyzed for complement, no hemolytic 
activity can be detected in a  sensitized sheep-cell system. If strongly bacteri- 
cidal sera are heated at 56°C. for 60 minutes, a considerable loss of bactericidal 
effect is observed. 
InitiaLly, a method for assay of serum inhibitor by dilution of serum in broth 
was considered desirable. It was observed, however, that as little as 0.3 ml. of 106  ACTIVATING  EFFECT  OF  CALCIUM 
Douglas broth added to 0.5 ml. of serum causes a  loss of bacterial inhibition. 
Dialysis (96 hours) of broth in distilled water partially removes the substances 
which reduce serum inhibitor for B, subtilis. 
Effect of Ionized Calcium on Serum Baaericidin.--The inhibition of the serum 
bactericidal substance by ordinary broth but not by dialyzed broth indicates 
that a salt effect may operate in the inactivation of the serum destructive factor. 
When  a  solution of 0.1  M Sorensen's phosphate buffer  (pH 7.3)  is added  to 
serum a  similar inactivation results. That this inhibition of serum bactericidal 
TABLE III 
E/fleet of Sodium Oxalate on the Bactericidal Activity of Serum for B. subtilis 
Serum 
No. 1 
Rheumatic 
fever 
No. 2 
Pneumonia 
No. 3 
Pneumonia 
~erum  0.5 ml 
Na~C~O,*  0.0  ml 
).85% 
NaCl  0.4  ml, 
Bacterialt 
suspen- 
sion  0.1 ml. 
60,000 
No growth 
No growth 
Serum  0.S ml.  ! 
Na2CsO4  0.1 ml,] 
~.ss% 
Nael  0.3 ml, 
Bacterial 
suspen- 
sion  0.t nil, 
>2,000,000 
1,200 
No growth 
Serum  0.5 ml.! 
NatCsO4  0.2 ml, 
3.8S% 
NaCl  0.2 ml, 
Bacterial 
I~uspcn- 
tion  0.1 mk 
>2,000,000 
>2,000,000 
No growth 
Serum  0.5 rnl. 
Na~C~O,  0.3 ml. 
~.ss% 
NaCl  O.l ml. 
Bacterial 
suspen-  i 
sion  0.l ml. 
>2,000,000 
>2,000,000 
41,000 
Serum  0.S ml, 
Na2C204  0.4 ml. 
0.aS% 
NaCI  0.0  mL 
Bacterial 
susl~n- 
sion  0.I ml. 
>2,000,000 
:> 2,000,000 
1,200,000 
Increasing concentrations of sodium oxalate were added to sera with varying degrees of 
bactericidal activity. A suspension of B. subtilis was added to each tube and the scram-bacteria 
mixture incubated for 2 hours at 37°C. The residual bacterial count was then made by plate 
count. 
* 0.1  M concentration  --  (1.34 rag./0.1 ml.) 
1,350,000 organisms/0.i  ml. 
substance is not due  to phosphate ion alone becomes apparent when sodium 
citrate or oxalate is added to serum. 
Table III is illustrative of the effect of sodium oxalatc on serum bactericidal 
activity. Increasing amounts of oxalate were added to 0.5 ml. aliquots of sera. 
In serum 1, 1.34 rag. of sodium oxalate causes a decrease in inhibitor effect for 
B. subtilis.  Serum 3, which has the highest bactericidal activity, requires 5.36 
rag. of sodium oxalate before a significant inhibition of bactericidal activity re- 
suits. If serum is treated in a similar manner with sodium citrate the bactericidal 
activity  decreases  as  the  concentration  of  sodium  citrate  is  increased.  The 
sodium salts of oxalic, citric, and phosphoric acids do not appear to have any 
growth-promoting effect on B. subtilis since addition of these salts to Douglas 
broth produces no difference from the growth obtained in a control broth after 
2 hours' incubation  at 37°C. RALPH 1  ~.  JACOX  107 
A complete restoration of the serum bactericidal effect is brought about if the 
oxalate or citrate is neutralized by equimolar concentrations of calcium chloride. 
This fact is shown in Table IV. 
Three-tenths millilitre amounts of 0.1 M  sodium oxalate were added to 0.5 ml. aliquots of 
strongly bactericidal sera. Fifteen minutes later, 0.3 ml. of 0.1 ~ CaCI.. was added, followed 
by 0.1 ml. of a suspension of B. subtilis. Upon incubation for 2 hours plate counts were made. 
It will be observed that complete inhibition of growth occurs in the untreated 
sera  whereas  the  oxalate-treated  serum  exhibits  no  inhibitory power for B. 
subtilis. The serum treated with both sodium oxalate and calcium chloride has 
TABLE IV 
Effect of Restoration of Optimum Calcium Concentration to Oxalated or Citrated Serum* 
0.1 ~  0.1 M  0.85per cent  0.1 tt  0.l  M  Bacterial  count 
Serum  NarCs0(  Na~Cdli0,  NaCl  CaCh  MgCh 
ml.  ml. 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.3 
0.3 
0.3 
0.3 
0.3 
0.3 
0.3 
0.3 
0.6 
ral. 
0.3 
0.3 
0.3 
0.3 
3,450,000 
160 
2,720,000 
2,070,000 
2,500,000 
120 
No growth 
* Serum from a patient with fever due to malaria inocula was treated with sodium oxalate 
or citrate as indicated in the table. Fifteen minutes later, calcium chloride, magnesium chlo- 
ride, or sodium chloride solutions were added. A 0.1 ml. suspension of B. subtilis containing 
1,000,000 organisms was added and after incubation for 2 hours at 37°C., the residual bac- 
terial count was determined. 
the same degree of bactericidal activity for B. subtilis as the untreated serum. 
When the oxalated serum is treated with an equimolar concentration of magne, 
slum chloride, no restoration of bactericidal activity is apparent. Results identi- 
cal to these are obtained when sodium citrate is substituted for sodium oxalate. 
Strongly reactive sera were  subjected  to dialysis against  distilled  water in 
order to determine whether the bactericidal activity could be removed by this 
technique.  A  measured  quantity of serum  was placed in  a  sterile  cellophane 
bag and dialyzed at 4°C. against frequent changes of distilled water for 5 days. 
Mter adjustment of pH to 7.3  and dilution with an equal amount of 0.85  per 
cent sodium chloride solution, a suspension of B. subtilis was added. The deter- 
mination of bactericidal activity by a plate count of the residual organisms after 
2 hours' incubation at 37°C.  revealed that no loss of inhibition had occurred. 
By means of cationic exchange resins, it has been shown that sufficient cal- 
cium can be removed from plasma to prevent coagulation (8). Acute phase sera 108  ACTIVATING  EF~FECT O1  ~ CALCIUM 
were  therefore  treated with a  cationic resin by the  technique described  by 
Quick (8). After adsorption in this manner, the sera were adjusted to pH 7.3 
with 0.1 N NaOH and the bactericidal activity was determined. No decrease in 
inhibitory effect for B. subtilis was found. 
These data show that calcium is a critical factor for the mediation of serum 
bactericidal activity against B.  subtilis.  The  failure of dialysis and cationic 
adsorption to decrease the inhibitory effect of serum suggests that sufficient 
bound calcium remains to maintain the bactericidal activity of these sera. 
Comparison of Bactericidal Effect of Serum for B. subtilis with the C-Reactive 
Protein:--Interesting similarities exist between the characteristics of the serum 
bactericidin for B.  subtilis  and  the  C-reactive protein described  by Tillett, 
Francis, Abernethy, Avery, MacLeod (9), and Ashe (10). These observers found 
that acute phase serum contains a protein which is reactive with the C carbo- 
hydrate of the pneumococcus. Moreover, this C-reactive protein does not pro- 
duce a  precipitin reaction unless calcium is present. More recently, L~ifstrom 
(11) has shown that an identical protein is reactive with a type 27 pneumococcus 
to cause non-specific capsular swelling. This reaction also requires calcium. 
Experiments were carried out to determine whether the C-reactive protein 
might be the same substance which causes destruction of B. subtilis. Human 
sera were selected which had increased amounts of C-reactive protein and bac- 
tericidal substance for B. subtilis. These sera were absorbed by the use of either 
C-carbohydrate  1 or type XXVII pneumococci.  1 Mter absorption, each serum 
was titrated against C-carbohydrate and type XXVII pneumococci. None of 
the  absorbed  sera  formed  a  precipitin  reaction  with  C-carbohydrate  or  a 
quellung reaction with type XXVII pneumococci, indicating that complete re- 
moval of C-reactive protein had resulted. A suspension of B. subtilis was then 
added to both absorbed and untreated sera and, after incubation for 2 hours, 
plate counts were made to determine the degree of bacterial inhibition. The 
results of this procedure (Table V) reveal that considerable bactericidal activity 
remains in absorbed sera. 
The heat stability of the C-reactive protein described by LSfstrom has been 
confirmed by our observation that the titre of acute phase sera for type XXVII 
pneumococci is not reduced by heating of serum at 5CC. for 60 minutes. If 
these  same heated sera  are  assayed for bactericidal activity for B.  subtilis, 
a marked reduction of destructive effect is found. This evidence suggests that 
the bactericidal activity of serum is not caused by the C-reactive protein. 
Simultaneous determinations of the C-reactive protein titre for type XXVII 
pneumoeoccus and bactericidal activity against B.  subtills were made in ap- 
1 Grateful acknowledgment is made to Julia M. Coffey, Division of Laboratories and Re- 
search, New York State Department of Health for supplying type XXVII pneumococci and 
to Dr. Charles Miller formerly of the Department of Bacteriology, School of Medicine  and 
Dentistry, Rochester,  New York, for supplying  the "C" carbohydrate of the pneumococctm RALPH F.  JACOX  109 
proximately 200 acute phase sera.  Usually a  parallel  increase and  decthne  of 
each substance are present in consecutive sera of patients with a  self-limited 
illness such  as pneumonia.  At  times, however, wide discrepancies are found. 
Occasionally a  serum is encountered  which  has a  significantly increased  titre 
for type XXVII pneumococcus but little inhibitory effect for B. subtilis. These 
observations are additional evidence that the C-reactive protein and the bac- 
tericidal substance in serum are different although each requires calcium before 
their characteristic effects are manifested. 
TABLE  V 
Effect of Removal of C-Reactive Protein on Bactericidal Activity  of Acute Phase Serum* 
C-reactive protein  Non-absorbed  sera diluted  Non-absorbed sera with 
Semra No.  removed by absorption  in 0.$$ per cent NaCi  sodium  oxalate added 
2~ 
3§ 
4§ 
s§ 
6§ 
7,000 
46,000 
6O0 
860 
50 
No growth 
1,900 
110 
No growth 
18 
No growth 
No growth 
300,000 
320,000 
310,000 
300,000 
210,000 
200,000 
* Serum was absorbed with either C  carbohydrate or type XXVII pneumococci until it 
no longer formed a precipitin or a quelling reaction. A 0.1 ml. suspension of B. subtilis con- 
taining 270,000 organisms was added to each serum sample and after incubation for 2 hours 
at 37°C., the bacterial count was determined. Three-tenths millilitre amounts of 0.1 M  sodium 
oxalate were added to untreated  sera in order to compare the growth characteristics of the 
inoculum under conditions of inhibited bactericidal activity. 
:~ Absorbed with equal volume of 1:10,000 C carbohydrate. 
§ Absorbed with packed type XXVII pneumococci. 
DISCUSSION 
A remarkable capacity of sera from patients with acute infections, carcinoma, 
or other diseases to destroy B.  subtilis  is revealed by this  investigation. The 
level of bactericidal activity appears to be closely related to the degree of stress 
caused by any pathological process. A maximum activity is present, for example, 
during the acute stage of pneumonia,  whereas a  decreasing destructive effect 
is present as the patient improves. Similarly, in acute rheumatic fever an in- 
creased  bactericidal  activity persists  as  long as  the  disease  is active, but  in 
convalescence a slow decrease occurs. When  evidences of a  disordered metab- 
olism, such as leucocytosis and fever, are absent as in some patients with car- 
cinoma, a  considerable increase of bactericidal activity for B.  sublilis  is often 
found. This latter  change does not,  therefore,  appear to be related  to leuco- 
cytosis, nor to any metabolic change associated with fever. 
Certain characteristics of the serum bactericidal substance are of significance 
in differentiating it from a  specific antibody protein. The one of greatest ira- II0  ACTIVATING  EFFECT  OF  CALCIUM 
portance is that the B. subt~s bactericidal factor requires calcium before de- 
struction of organisms can take place. The evidence for this is found in experi- 
ments in which decalcification of serum by means of sodium salts of phosporic, 
citric, or oxalic acids causes a loss of serum inhibitory activity. When equimolar 
concentrations of ionized calcium are added to sera treated in this manner, a 
restoration of inhibitory activity occurs. That the effect of calcium is specific 
is shown by the fact that similar concentrations of ionized magnesium fail to 
completely restore bactericidal activity. Since dialysis of serum or treatment 
with cationic exchange resins fails to diminish bactericidal activity, it seems 
likely that the serum bactericidal effect can be maintained by the residual bound 
calcium. 
The stability of serum bactericidin for B. suhtilis after prolonged storage at 
4°C. differentiates it from the heat-labile fraction of complement. Moreover, 
the fact that calcium and not magnesium restores bactericidal activity is fur- 
ther evidence that the bactericidin differs from complement (12). 
A striking similarity  exists between the C-reactive protein described by Tillett 
and Francis (9) and serum bactericidal activity for B. subt~is. Each is increased 
as a result of acute infection, and each requires calcium. By means of absorp- 
tion experiments and by the differential effect of heating of sera it appears, 
however, that these two serum factors are actually different. Furthermore, cer- 
tain sera were found to contain considerably increased amounts of C-reactive 
protein yet had little bactericidal activity for B. subtilis.  These observations 
point out dissimilarities of the two substances despite the fact that both have 
an intimate relationship to calcium. 
The reported instances of increased bactericidal activity of acute phase sere 
for various microorganisms suggest that the serum bactericidal agent for B. 
anthracis  (5), Streptococcus kemolyticus  (6),  and other microorganisms (7) may 
depend on a  single bactericidin-calcium substance which is unrelated to com- 
plement or a specific antibody function. If this hypothesis is substantiated by 
subsequent investigations, a means of body defense against bacterial invasion, 
uniquely different from the complement-antibody destructive action and the 
phagocytic reaction, may be revealed. 
SUMMARY 
An enhanced bactericidal activity of human serum for B. subtilis develops 
during many different forms of illness,  e.g. carcinoma, virus and bacterial in- 
fections, and during acute  coronary occlusion. 
This increased bactericidal effect cannot be  related to  leucocytosis, fever, 
serum complement, C-reactive protein, or a  specific antibody reaction. 
The  serum  bactericidal factor becomes  inactive in  decalcified  serum,  but 
active again when optimal concentrations of calcium are  added. Magnesium 
does not cause reactivation. RALPH  F.  ~ACOX  111 
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